Ryan Cohlhepp, President, COO & Interim CEO at Bicara Therapeutics, sold BCAX on Sep 8, 2026
Data as of Oct 27
▼ SELL$80.7K3,442 shares at $23.43Ryan Cohlhepp President, COO & Interim CEOBCAX Bicara Therapeutics Inc.
- Traded
- Sep 8, 2026
- Disclosed
- Sep 10, 2026
- Filed
- 2 days after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
BCAX since disclosure
−24.3%
after the sale
Similar stocks (XLV) since disclosure
+8.2%
XLV — its sector index fund
Change in closing price from Sep 10, 2026 (the first trading day on or after disclosure) to Oct 27, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.
Other trades in the same filing
- ▼ SELLRyan Cohlhepp President, COO & Interim CEOBCAX Bicara Therapeutics Inc.$320Kdisclosed Sep 10 · filed 2 days after the trade